As most tumors respond readily to dopamine agonists in terms of reductions in prolactin levels and decreased volume, radiotherapy should now rarely be used in the treatment of prolactinoma.

When she was diagnosed with a tumour at 16, Eunice Wong Luo Ee experienced a deep sense of helplessness and fear.

The 19-year-old’s journey to pursuing tertiary studies had been met with obstacles. With his family of three struggling ...

We report a case of SUNCT syndrome secondary to a prolactinoma. Administration of dopamine agonists led to complete resolution of the SUNCT attacks. This case, together with other similar case reports ...

Br J Ren Med. 2020;25(1):14-15. National Institute of Diabetes and Digestive and Kidney Diseases. Prolactinoma. Levine S, Muneyyirci-Delale O. Stress-induced hyperprolactinemia: pathophysiology and ...

Mixed lineage kinase domain-like protein (MLKL) is a pseudokinase featured by a protein kinase-like domain without catalytic activity. MLKL was originally discovered to be phosphorylated by ...